Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ILOPERIDONE, MICRONIZED, with a corresponding US DMF Number 27910.
Remarkably, this DMF maintains an Active status since its submission on April 17, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2014, and payment made on March 26, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II